U.S. Digital Therapeutics Market - Infographics -AMR

The diabetes segment accounted more than one-fifth of the total U.S. Digital Therapeutics Market share in 2019.

PORTLAND, OREGON, UNITED STATES, February 23, 2024 /EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, “U.S. Digital Therapeutics Market by Application, Product, and Sales Channel: Opportunity Analysis and Industry Forecast, 2020–2027,"the U.S. digital therapeutics market was valued at $1.16 billion in 2019 and is expected to reach $5.08 billion by 2027 with a CAGR of 19.2% from 2020 to 2027. The diabetes segment accounted more than one-fifth of the total market share in 2019.

𝑹𝒆𝒒𝒖𝒆𝒔𝒕 𝑺𝒂𝒎𝒑𝒍𝒆 𝑪𝒐𝒑𝒚 𝒐𝒇 𝑹𝒆𝒑𝒐𝒓𝒕- https://www.alliedmarketresearch.com/request-sample/7066

Digital therapeutics, a subset of digital health, provides evidence-based therapeutic interventions through software programs and devices to manage, prevent, and treat medical disorders. Leveraging digital and online health technologies, it delivers clinical-grade treatments while enabling tracking of patient behavior and remote monitoring for improved long-term health outcomes.

The distribution of digital therapeutics products for mental health has surged amidst the COVID-19 pandemic, driving growth in the U.S. market. This trend underscores the acknowledgment by the U.S. FDA of the importance of such products. Additionally, U.S. digital health companies have witnessed a record-high influx of venture funding in the first half of 2020, reflecting investors' recognition of the necessity and potential of these solutions. Consequently, these factors collectively propel the growth of the U.S. digital therapeutics market.

The increasing adoption of smartphones, tablets, and smart wearables, alongside the proliferation of healthcare apps, underscores the pressing need to manage healthcare costs and address the rising prevalence of chronic diseases. Additionally, the uptake of advanced technologies and tech-driven healthcare products and applications further accelerates market growth. However, challenges such as the absence of reimbursement policies for digital therapeutics and concerns regarding patient data privacy hinder market expansion. Conversely, favorable regulatory frameworks for digital health technology and rising investments in digital therapeutics present promising opportunities for manufacturers in the U.S. digital therapeutics industry.

𝑭𝒐𝒓 𝑷𝒖𝒓𝒄𝒉𝒂𝒔𝒆 𝑬𝒏𝒒𝒖𝒊𝒓𝒚 𝒂𝒕: https://www.alliedmarketresearch.com/purchase-enquiry/7066

Within specific applications, the obesity segment is poised to exhibit substantial growth, with a projected CAGR of 22.1% during the forecast period, driven by the escalating rates of obesity across the nation. According to the CDC, the prevalence of obesity in the U.S. was approximately 42.4% from 2017 to 2018.

In terms of product segments, the software segment dominated the U.S. digital therapeutics market in 2019, capturing about two-thirds of the market share. This dominance is attributed to the widespread adoption of smartphones in the country, leading to increased usage of healthcare applications.

𝑳𝒆𝒂𝒅𝒊𝒏𝒈 𝒎𝒂𝒓𝒌𝒆𝒕 𝒑𝒍𝒂𝒚𝒆𝒓𝒔
2MORROW, Inc.
Fitbit, Inc. (Twine Health, Inc.)
Livongo Health, Inc.
Medtronic Plc.
Omada Health, Inc.
Pear Therapeutics, Inc.
Proteus Digital Health, Inc.
Resmed, Inc. (Propeller Health)
Voluntis, Inc.
Welldoc, Inc.

𝑶𝒖𝒓 𝑴𝒂𝒓𝒌𝒆𝒕 𝑹𝒆𝒔𝒆𝒂𝒓𝒄𝒉 𝑺𝒐𝒍𝒖𝒕𝒊𝒐𝒏 𝑷𝒓𝒐𝒗𝒊𝒅𝒆𝒔 𝒀𝒐𝒖 𝑨𝒏𝒔𝒘𝒆𝒓 𝒕𝒐 𝑩𝒆𝒍𝒐𝒘 𝑴𝒆𝒏𝒕𝒊𝒐𝒏𝒆𝒅 𝑸𝒖𝒆𝒔𝒕𝒊𝒐𝒏:
Which are the driving factors responsible for the growth of market?
Which are the roadblock factors of this market?
What are the new opportunities, by which market will grow in coming years?
What are the trends of this market?
Which are main factors responsible for new product launch?
How big is the global & regional market in terms of revenue, sales and production?
How far will the market grow in forecast period in terms of revenue, sales and production?
Which region is dominating the global market and what are the market shares of each region in the overall market in 2019?
How will each segment grow over the forecast period and how much revenue will these segments account for in 2027?
Which region has more opportunities?

𝑶𝒕𝒉𝒆𝒓 𝑻𝒓𝒆𝒏𝒅𝒊𝒏𝒈 𝑹𝒆𝒑𝒐𝒓𝒕𝒔 𝒊𝒏 𝑳𝒊𝒇𝒆 𝑺𝒄𝒊𝒆𝒏𝒄𝒆 𝑫𝒐𝒎𝒂𝒊𝒏
𝑫𝒓𝒖𝒈 𝑫𝒆𝒍𝒊𝒗𝒆𝒓𝒚 𝑫𝒆𝒗𝒊𝒄𝒆𝒔 𝑴𝒂𝒓𝒌𝒆𝒕 https://www.alliedmarketresearch.com/drug-delivery-devices-market-A06095
𝑨𝒏𝒆𝒔𝒕𝒉𝒆𝒔𝒊𝒂 𝑴𝒂𝒄𝒉𝒊𝒏𝒆𝒓𝒚 𝑴𝒂𝒓𝒌𝒆𝒕 https://www.alliedmarketresearch.com/anesthesia-machinery-market-A06271

David Correa
Allied Market Research
+1 5038946022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.